RELVAR

fluticasone furoate/vilanterol · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RELVAR, covering 2019-12-04 to 2025-02-18. Get the full timeline:

Most recent: Clinical Trial Update: RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD [Phase 4]